Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8361029 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US10737028 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US8313466 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US7918823 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US10314977 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US8608698 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US8425462 | KALEO INC | Devices, systems, and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US9737669 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US9056170 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
US7731690 | KALEO INC | Devices, systems and methods for medicament delivery |
Jan, 2025
(8 months from now) | |
US8016788 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2025
(10 months from now) | |
US10335549 | KALEO INC | Devices, systems and methods for medicament delivery |
Apr, 2025
(1 year, 4 days from now) | |
US9278182 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2026
(1 year, 9 months from now) | |
US8926594 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2026
(1 year, 11 months from now) | |
US7731686 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
US10960155 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
US11590286 | KALEO INC | Devices, systems and methods for medicament delivery |
Dec, 2026
(2 years from now) | |
US9238108 | KALEO INC | Medicament delivery device having an electronic circuit system |
Feb, 2027
(2 years from now) | |
US8206360 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2027
(2 years from now) | |
US9724471 | KALEO INC | Devices, systems, and methods for medicament delivery |
May, 2027
(3 years from now) | |
US7947017 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2028
(3 years from now) | |
US7749194 | KALEO INC | Devices, systems, and methods for medicament delivery |
Oct, 2028
(4 years from now) | |
US8231573 | KALEO INC | Medicament delivery device having an electronic circuit system |
Nov, 2028
(4 years from now) | |
US8226610 | KALEO INC | Medical injector with compliance tracking and monitoring |
Apr, 2029
(4 years from now) | |
US8223610 | KALEO INC | Apparatus and method for initializing information recording medium, apparatus and method for recording information, and information recording medium |
Apr, 2029
(4 years from now) | |
US8021344 | KALEO INC | Medicament delivery device configured to produce an audible output |
Nov, 2029
(5 years from now) | |
US9022022 | KALEO INC | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Feb, 2031
(6 years from now) | |
US8939943 | KALEO INC | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Feb, 2031
(6 years from now) | |
US10322239 | KALEO INC | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Feb, 2031
(6 years from now) | |
US9474869 | KALEO INC | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Feb, 2031
(6 years from now) | |
US10143972 | KALEO INC | Ultrafiltration membrane and a preparation method thereof |
May, 2031
(7 years from now) | |
US8627816 | KALEO INC | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Feb, 2032
(7 years from now) | |
US9517307 | KALEO INC | Devices and methods for delivering opioid antagonists including formulations for naloxone |
Jul, 2034
(10 years from now) | |
US10220158 | KALEO INC | Devices and methods for delivering opioid antagonists including formulations for naloxone |
Mar, 2035
(10 years from now) |
Evzio is owned by Kaleo Inc.
Evzio contains Naloxone Hydrochloride.
Evzio has a total of 34 drug patents out of which 0 drug patents have expired.
Evzio was authorised for market use on 03 April, 2014.
Evzio is available in solution;intramuscular, subcutaneous dosage forms.
Evzio can be used as use of a delivery device to deliver a dose of naloxone, use of a delivery device to administer a dose of naloxone, method for confirming dose delivery, use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle, use of an auto injector to administer naloxone hcl.
The generics of Evzio are possible to be released after 20 March, 2035.
Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient
Market Authorisation Date: 03 April, 2014
Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone h...
Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS